Biofarm's Net Profit Plunges 17% YoY To RON42M In H1/2024
<img src="http://storage0.dms.mpinteractiv.ro/media/401/1561/19649/22467817/1/biofarm-day2-8776-002-1.jpg?width=160&height=120"/> Pharmaceutical producer Biofarm Bucuresti (stock symbol: BIO) ended the first half of 2024 with net profit of RON42 million, down 17% from RON50.2 million reported in the same period of 2023, as per its half-yearly financial report.

														<br/><br/><a href="https://core.adservingfactory.com/click?spgid=0&__x1ts=&pub=62&site=4268&section=0&zone=2008&size=0x0&__x1cguid=178">
					<img src="https://core.adservingfactory.com/ad?__x1ns=1&spgid=0&pub=632203491294404&site=rss.zf&section=site&zone=RSS_feed&size=300x250&__x1cguid=178" border="0" alt=""/>
					</a>